Organometallics
Article
2 H, CH(CH3)2, 3J(H,H) = 6.9 Hz), 1.74 (d, 12 H, CH(CH3)2,
3J(H,H) = 6.9 Hz). 13C{1H} NMR (125.76 MHz, CDCl3): δ 214.8 (s,
NCS), 186.2 (s, NCN), 143.7, 134.5, 133.2, 131.3, 130.4, 129.9, 129.4,
127.7, 127.1, 125.3, 123.7, 116.9, 113.9, 113.8 (s, Ar-C), 59.4 (s,
CH2Ph), 54.7 (s, CH(CH3)2), 23.0 (s, CH(CH3)2). 19F NMR (282.4
MHz, CDCl3): δ −75.92 (s, 10BF4), −75.97 (s, 11BF4). MS (ESI): m/z
624 [M − PF6]+. Anal. Calcd for C27H29AuBF4N3S: C, 45.59; H, 4.11;
N, 5.91. Found: C, 45.61; H, 4.31; N, 6.04.
6 H, NCH3), 4.59 (s, 3 H, NCH3), 1.87 (CH(CH3)2, d, 12 H, 3J(H,H)
= 6.5 Hz). 13C{1H} NMR (75.47 MHz, CD2Cl2): δ 168.6 (s, NCHN,
ditz), 153.4 (s, NCHN, Pr2-bimy), 133.4, 125.8, 114.9 (s, Ar-C), 56.4
(s, CH(CH3)2), 41.6 (s, NCH3), 39.8 (s, NCH3), 21.3 (s, CH(CH3)2).
19F NMR (300 MHz, CD2Cl2): δ −76.75 (s, 10BF4), −76.80 (s, 11BF4).
MS (ESI): m/z 1138 [M − BF4]+, 526 [M − 2BF4]2+. Anal. Calcd for
C31H45Au2B2Cl4F8N7: C, 30.39; H, 3.70; N, 8.00. Found: C, 30.18; H,
3.87; N, 7.82.
i
[PdBr2(Indy)(iPr2-bimy)] (1′). Dimeric complex D (105 mg, 0.11
mmol) and Indy·H+Br− (57 mg, 0.23 mmol) were suspended in
CH2Cl2 (25 mL). Ag2O (36 mg, 0.16 mmol) was added to the
mixture, and the resulting suspension was stirred for 12 h while it was
shielded from light. The reaction mixture was then filtered over Celite,
and the solvent of the filtrate was removed under vacuum, yielding the
crude product. The crude product was redissolved in a minimal
volume of CHCl3, and the solution was filtered over Celite. A large
excess of diethyl ether was added to the filtrate to precipitate the
product. The precipitate was collected and dried under vacuum,
yielding the product as a pale orange powder (125 mg, 0.20 mmol,
87%). 1H NMR (500 MHz, CDCl3): δ 8.54 (d, 1 H, Ar-H), 7.54−7.64
(m, 3 H, Ar-H), 7.36 (t, 1 H, Ar-H), 7.27 (d, 1 H, Ar-H), 7.23 (dd, 2
H, Ar-H), 6.47 (br m, 1 H, NCH), 6.23 (br m, 1 H, NCH), 5.08 (br t,
2 H, NCH2), 4.01 (br t, 2 H, NCH2), 2.25 (br m, 4 H, CH2), 1.93 (br
d, 6 H, CH3), 1.87 (br d, 6 H, CH3). 13C{1H} NMR (125.8 MHz,
CDCl3): δ 181.4 (s, Ccarbene (iPr2-bimy)), 179.6 (s, Ccarbene (Indy)),
142.9, 134.5, 134.3, 131.9, 131.6, 130.5, 123.3, 122.5, 113.2, 109.6 (s,
Ar-C), 54.3 (s, NCH), 53.1, 48.4 (s, NCH2), 23.3, 22.1 (s, CH2), 21.9
(s, CH3). MS (ESI): m/z 561 [M − Br]+. Anal. Calcd for
C24H30N4PdBr2: C, 44.99; H, 4.72; N, 8.74. Found: C, 45.00; H,
4.93; N, 8.57.
[Au(IPr)(iPr2-bimy)]BF4 (5). The general procedure afforded the
1
product as a white solid (77 mg, 0.088 mmol, 88%). H NMR (500
MHz, CDCl3): δ 7.64−7.27 (m, 12 H, Ar-H), 4.36 (m, 2 H,
3
3
CH(CH3)2, J(H,H) = 6.9 Hz), 2.56 (m, 4 H, CH(CH3)2, J(H,H) =
6.9 Hz), 1.27−1.24 (d, 36 H, CH(CH3)2, 3J(H,H) = 6.9 Hz). 13C{1H}
NMR (125.76 MHz, CDCl3): δ 187.3 (s, NCN−IPr), 186.7 (s,
NCN-iPr2-bimy), 146.6, 134.5, 133.0, 131.6, 125.4, 125.2, 125.0, 113.5
(s, Ar-C), 53.9 (s, CH(CH3)2-iPr2-bimy), 29.5 (s, CH(CH3)2-IPr),
25.2, 24.8, 22.6 (s, CH(CH3)2). 19F NMR (282.37 Hz, CDCl3): δ
−77.90 (s, 10BF4), −77.94 (s, 11BF4). MS (ESI): m/z 788 [M − BF4]+.
Anal. Calcd for C40H54AuBF4N4: C, 54.93; H, 6.22; N, 6.41. Found: C,
54.90; H, 6.13; N, 6.25.
[Au(IPr)(iPr2-bimy)]PF6 (6). The general procedure afforded the
1
product as a white solid (80 mg, 0.086 mmol, 86%). H NMR (300
MHz, CDCl3): δ 7.64−7.27 (m, 12 H, Ar-H), 4.36 (m, 2 H,
3
3
CH(CH3)2, J(H,H) = 6.9 Hz), 2.57 (m, 4 H, CH(CH3)2, J(H,H) =
6.9 Hz), 1.27 (d, 24 H, CH(CH3)2, 3J(H,H) = 6.9 Hz), 1.26 (d, 12 H,
CH(CH3)2, 3J(H,H) = 6.9 Hz). 13C{1H} NMR (75.47 MHz, CDCl3):
δ 187.3 (s, NCN−IPr), 186.7(s, NCN-iPr2-bimy), 146.5, 134.5, 133.0,
131.6, 125.3, 125.1, 125.0, 113.5 (s, Ar-C), 53.9 (s, CH(CH3)2-iPr2-
bimy), 29.4 (s, CH(CH3)2-IPr), 25.1, 24.8, 22.6 (s, CH(CH3)2). 31P
2
NMR (121.49 MHz, CDCl3): δ −143.7 (sept, J(P,F) = 712.4 Hz).
[PdBr2(Bn-btay)(iPr2-bimy)] (4′). The precursor salt iPr2-
bimy·H+Br− (16 mg, 0.06 mmol) and Ag2O (7 mg, 0.03 mmol)
were suspended in CH2Cl2 (5 mL) and stirred for 3 h. The resulting
mixture was filtered into a CH2Cl2 solution of dimeric complex E (28
mg, 0.03 mmol) and stirred for 1 h. The suspension was filtered over
Celite, and the solvent of the filtrate was removed under vacuum. The
product was obtained as a yellow solid after recrystallization from
CH2Cl2/toluene (32 mg, 0.05 mmol, 82%). 1H NMR (300 MHz,
CDCl3): δ 7.85−7.83 (m, 1 H, Ar-H), 7.65−7.59 (m, 5 H, Ar-H),
7.43−7.34 (m, 5 H, Ar-H), 7.21−7.18 (m, 2 H, Ar-H), 6.54 (s, 2 H,
NCH2), 6.05 (m, 2 H, CH(CH3)2, 3J(H, H) = 7.1 Hz), 1.71 (d, 12 H,
CH(CH3)2, 3J(H, H) = 7.1 Hz). 13C{1H} NMR (75.48 MHz, CDCl3):
δ 217.7 (s, NCS), 176.4 (s, NCN-iPr2-bimy), 144.3, 137.2, 135.0,
134.3, 129.7, 128.9, 128.1, 127.3, 125.6, 122.8, 122.7, 115.3, 113.3 (s,
Ar-C), 59.1 (s, NCH), 54.6 (s, NCH2), 21.6 (s, CH3). MS (ESI): m/z
614 [M − Br]+. Anal. Calcd for C27H29Br2N3PdS: C, 46.74; H, 4.21;
N, 6.06. Found: C, 46.39; H, 4.55; N, 5.66.
2
19F NMR (282.37 Hz, CDCl3): δ 2.395 (d, J(P,F) = 712.4 Hz). MS
(ESI): m/z 788 [M − PF6]+. Anal. Calcd for C40H54AuF6N4P: C,
51.50; H, 5.83; N, 6.01. Found: C, 51.74; H, 5.57; N, 5.55.
[Au(iPr2-bimy)]2(μ-ditz)(BF4)2 (7). The general procedure followed
by flash column chromatography (ethyl acetate) afforded 7 as a white
solid (52 mg, 0.048 mmol, 48%). Complex 7 could be alternatively
1
synthesized via Ag−carbene transfer method in a yield of 56%. H
NMR (500 MHz, CDCl3): δ 7.68−7.66 (m, 4 H, Ar-H), 7.39−7.37
(m, 4 H, Ar-H), 5.31 (m, 4 H, CH(CH3)2, 3J(H,H) = 7.0 Hz), 4.31 (s,
6 H, NCH3), 4.13 (s, 3 H, NCH3), 1.75 (d, 24 H, 3J(H,H) = 7.0 Hz).
13C{1H} NMR (125.76 MHz, CDCl3): δ 189.4 (s, NCHN, ditz), 185.6
(s, NCHN, iPr2-bimy), 133.0, 125.1, 113.7 (s, Ar-C), 54.5 (s,
CH(CH3)2), 40.5 (s, NCH3), 38.6 (s, NCH3), 22.9 (s, CH(CH3)2).
19F NMR (282.37 Hz, CDCl3): δ −77.30 (s, 10BF4), −77.35 (s, 11BF4).
MS (ESI): m/z 455 [M − 2BF4]2+, 996 [M − BF4]+. Elemental
analyses were not available due to fast decomposition.
[AuCl2(Bn2-bimy)(iPr2-bimy)]BF4 (12). Complex 3 (78 mg, 0.1
mmol) and PhICl2 (30 mg, 0.11 mmol) were mixed, and CH2Cl2 (10
mL) was added. The reaction mixture was stirred at ambient
temperature overnight while it was shielded from light. All volatiles
were removed under vacuum, and the residue was washed with diethyl
ether (3 × 5 mL), yielding an off-white solid (75 mg, 0.87 mmol,
[PdBr2(FPyr)(iPr2-bimy)] (8′). Dimeric complex D (99 mg, 0.11
mmol) and FPyr·H+Br− (54 mg, 0.21 mmol) were suspended in
CH2Cl2 (20 mL). Ag2O (29 mg, 0.13 mmol) was added to the
mixture, and the resulting suspension was stirred for 12 h while it was
shielded from light. The reaction mixture was then filtered over Celite,
and the solvent of the filtrate was removed under vacuum, yielding the
crude product. Recrystallization of the crude product from a solution
in CH2Cl2 layered with toluene produced a yellow crystalline product
(113 mg, 0.18 mmol, 83%). 1H NMR (500 MHz, CDCl3): δ 7.52 (dd,
2 H, Ar-H), 7.16 (dd, 2 H, Ar-H), 6.31 (m, 1 H, NCH, 3J(H,H) = 6.95
1
87%). H NMR (300 MHz, CD2Cl2): δ 7.72−7.71 (m, 4 H, Ar-H),
7.61−7.60 (m, 2 H, Ar-H), 7.48−7.46 (m, 8 H, Ar-H), 7.32−7.29 (m,
4 H, Ar-H), 6.03 (s, 4 H, CH2Ph), 4.49 (m, 2 H, CH(CH3)2, 3J(H,H)
3
= 6.9 Hz), 1.53 (d, 12 H, CH(CH3)2, J(H,H) = 6.9 Hz). 13C{1H}
3
NMR (75.47 MHz, CD2Cl2): δ 165.3 (s, NCN, Bn2-bimy), 158.7 (s,
NCN, iPr2-bimy), 134.5, 134.0, 133.0, 129.8, 129.3, 127.0, 126.7, 125.6
(s, Ar-C), 55.4 (s, CH2Ph), 51.3 (s, CH(CH3)2), 21.1 (s, CH(CH3)2).
19F NMR (282.4 MHz, CD2Cl2) δ −77.52 (s, 10BF4), −77.57 (s,
11BF4). MS (ESI): m/z 769 [M − BF4]+. Anal. Calcd for
C34H36AuBF4N4: C, 47.74; H, 4.24; N, 6.55. Found: C, 47.66; H,
4.19; N, 6.68.
Hz), 6.13 (m, 1 H, NCH, J(H,H) = 6.95 Hz), 4.75 (t, 2 H, NCH2,
3J(H,H) = 5.70 Hz), 3.84 (t, 2 H, NCH2, 3J(H,H) = 5.65 Hz), 2.93 (t,
2 H, CH2, 3J(H,H) = 5.65 Hz), 2.43 (t, 2 H, CH2, 3J(H,H) = 6.30 Hz),
2.14 (m, 2 H, CH2), 2.08 (m, 2 H, CH2), 1.84 (d, 6 H, CH3, 3J(H,H)
3
= 6.95 Hz), 1.81 (d, 6 H, CH3, J(H,H) = 6.95 Hz) (signals due to
another two CH2 groups of the FPyr ligand were overlapped with the
i
signals due to the CH3 groups of the Pr2-bimy ligand, in the 1.75−
[AuCl2(iPr2-bimy)]2(μ-ditz)(BF4)2 (13). This complex was synthe-
sized in analogy to the procedure for complex 12, with the exception
of decreasing the reaction temperature to 0 °C. Fractional
1.85 ppm region). 13C{1H} NMR (125.8 MHz, CDCl3): δ 184.0 (s,
Ccarbene (iPr2-bimy)), 171.4 (s, Ccarbene (FPyr)), 142.5 (s, NCCH2),
134.6 (s, Ar-C), 134.3 (s, Ar-C), 125.2 (s, NCcarbeneCCH2), 122.3 (s,
Ar-C), 113.0 (s, Ar-C), 54.1 (s, NCH), 53.9 (s, NCH), 51.2 (s,
NCH2), 46.0 (s, NCH2), 23.6, 23.1, 22.8, 22.7, 22.03, 21.99, 21.7, 21.4
(s, CH2 and CH3). MS (ESI): m/z 565 [M − Br]+. Anal. Calcd for
1
crystallization afforded 13 as an off-white solid in a yield of 81%. H
NMR (500 MHz, CD2Cl2): δ 7.86−7.85 (Ar-H, m, 4H), 7.54−7.52
(Ar-H, m, 4 H), 5.38 (CH(CH3)2, m, 4 H, 3J(H,H) = 6.5 Hz), 4.60 (s,
K
dx.doi.org/10.1021/om400313r | Organometallics XXXX, XXX, XXX−XXX